SENSEX NIFTY
Apr 22, 2016, 06.47 PM | Source: PTI

Omron Healthcare India eyes 30% revenue growth in 2016

Expressing confidence on the growth plans of the firm for the year, Omron Healthcare India Managing Director Hisao Masuda said: "We recognise the potential that India offers as a market and (the company) will witness a 30 percent growth this year."

Omron Healthcare India eyes 30% revenue growth in 2016
Japanese health monitoring products maker Omron Healthcare is looking at a revenue growth of 30 percent in India this year as it undertakes several initiatives to expand presence in the country.

Expressing confidence on the growth plans of the firm for the year, Omron Healthcare India Managing Director Hisao Masuda said: "We recognise the potential that India offers as a market and (the company) will witness a 30 percent growth this year."

To achieve this, the company is working to penetrate deeper into the Indian market. It is seeking to be present in 26 cities by the end of 2016 from the current 16, the company said in a statement.

It is also looking to increase awareness on the importance of daily home monitoring and explore e-commerce business, it added.

"Our vision is to contribute to the advancement of India's healthy life through business operations and we are working to be the number one healthcare company in India," Masuda said.

India is a very strong and potential market due to rise in awareness level among the population and people are addressing their health issues at basic levels, where the company plays a major role, it said.

Omron Healthcare India's products include blood pressure monitors, blood glucose monitors, nebulisers and body composition monitors.

READ MORE ON  health, Omron Healthcare, India

ADS BY GOOGLE



video of the day

Expect Nifty to bottom out pre-RBI policy: Sabharwal

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.